BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Business

  Mersana Therapeutics, Inc. And Takeda Pharmaceutical Co. Ltd. Enter Commercial License Agreement For Novel Fleximer® Antibody-Drug Conjugate

  October 27, 2014

   · 

  1 min read
• Compugen Ltd. Discloses Successful Validation Results For Novel B7/CD28–like Cancer Immunotherapy Target Candidate

  October 27, 2014

   · 

  6 min read
• Business

  Allergan Inc. Announces Quarterly Conference Call

  October 27, 2014

   · 

  1 min read
• Business

  Harvard Apparatus Regenerative Technology Schedules Release Of Third Quarter 2014 Financial Results And Investor Teleconference For November 6, 2014

  October 27, 2014

   · 

  1 min read
• Business

  Merck & Co. Announces Third-Quarter 2014 Financial Results

  October 27, 2014

   · 

  1 min read
• FDA

  Essential Medical, Inc. Announces CE Mark Approval For New Vascular Closure Device, X-Seal™

  October 27, 2014

   · 

  1 min read
• Imaxio Release: France’s National Research Agency Selects The OPTIVAC Project And Contributes €600,000 ($772,000) To Improve The Efficacy Of Influenza Vaccines

  October 27, 2014

   · 

  6 min read
• Business

  Galena Biopharma To Report Third Quarter 2014 Financial Results On Monday, November 3, 2014

  October 27, 2014

   · 

  1 min read
• Business

  CareDx To Release Third Quarter 2014 Financial Results And Host Conference Call On Monday, November 10, 2014

  October 27, 2014

   · 

  1 min read
• Business

  Mersana Therapeutics, Inc. And Takeda Enter Commercial License Agreement For Novel Fleximer® Antibody-Drug Conjugate

  October 27, 2014

   · 

  3 min read